Julia Albrecht
Overview
Explore the profile of Julia Albrecht including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
265
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thuresson A, Brazina J, Akram T, Albrecht J, Dahl N, Soussi Zander C, et al.
Mol Genet Genomic Med
. 2023 Nov;
12(1):e2295.
PMID: 37916443
Background: Microcephaly with early-onset seizures (MCSZ) is a neurodevelopmental disorder caused by pathogenic variants in the DNA strand break repair protein, polynucleotide kinase 3'-phosphatase (PNKP). Methods: We have used whole...
2.
Klumper N, Ralser D, Ellinger J, Roghmann F, Albrecht J, Below E, et al.
Clin Cancer Res
. 2022 Dec;
29(8):1496-1505.
PMID: 36534531
Purpose: The antibody-drug conjugate enfortumab vedotin (EV) releases a cytotoxic agent into tumor cells via binding to the membrane receptor NECTIN-4. EV was recently approved for patients with metastatic urothelial...
3.
Odendahl M, Grigoleit G, Bonig H, Neuenhahn M, Albrecht J, Anderl F, et al.
Cytotherapy
. 2014 Aug;
16(9):1245-56.
PMID: 25108651
Background Aims: Reactivation of cytomegalovirus (CMV) after hematopoietic stem cell transplantation remains a major cause of morbidity despite improved antiviral drug therapies. Selective restoration of CMV immunity by adoptive transfer...
4.
Stemberger C, Graef P, Odendahl M, Albrecht J, Dossinger G, Anderl F, et al.
Blood
. 2014 May;
124(4):628-37.
PMID: 24855206
Patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) are threatened by potentially lethal viral manifestations like cytomegalovirus (CMV) reactivation. Because the success of today's virostatic treatment is limited by side...
5.
Kutscher S, Dembek C, Deckert S, Russo C, Korber N, Bogner J, et al.
PLoS One
. 2013 Oct;
8(10):e76215.
PMID: 24146841
Polyfunctional CD4 or CD8 T cells are proposed to represent a correlate of immune control for persistent viruses as well as for vaccine mediated protection against infection. A well-suited methodology...
6.
Dossinger G, Bunse M, Bet J, Albrecht J, Paszkiewicz P, Weissbrich B, et al.
PLoS One
. 2013 May;
8(4):e61384.
PMID: 23637823
Adoptive therapy using T cells redirected to target tumor- or infection-associated antigens is a promising strategy that has curative potential and broad applicability. In order to accelerate the screening process...
7.
Albrecht J, Garbade S, Burgard P
Neurosci Biobehav Rev
. 2008 Nov;
33(3):414-21.
PMID: 19038285
Although pathogenesis of phenylketonuria is not completely understood, a low phenylalanine diet is effective to prevent severe neurological impairment, mental retardation and behavioural difficulties. Treatment recommendations heavily rely on neuropsychological...
8.
Harle P, Pongratz G, Albrecht J, Tarner I, Straub R
Arthritis Rheum
. 2008 Aug;
58(8):2347-55.
PMID: 18668589
Objective: Activation of the sympathetic nervous system (SNS) ameliorates collagen-induced arthritis (CIA) in the late phase of the disease but aggravates it in the presymptomatic phase. The aim of the...
9.
Hoffmann P, Boeld T, Eder R, Albrecht J, Doser K, Piseshka B, et al.
Biol Blood Marrow Transplant
. 2006 Mar;
12(3):267-74.
PMID: 16503495
The adoptive transfer of donor CD4+CD25+ regulatory T cells has been shown to protect from lethal graft-versus-host disease after allogeneic bone marrow transplantation in murine disease models. Efficient isolation strategies...